TNFAIP8L1 — TNF Alpha Induced Protein 8 Like 1

Migration, Crosslink

📖

TNFAIP8L1 — TNF Alpha Induced Protein 8 Like 1

active

wiki page Created: 2026-04-02T07:19:25 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-tnfaip8l1

📖 Wiki Page

gene1794 wordssynced 2026-04-02

TNFAIP8L1 — TNF Alpha Induced Protein 8 Like 1

Overview

TNFAIP8L1 (TNF Alpha Induced Protein 8 Like 1), also known as TIPE2 (TNFAIP8-like-2), is a member of the TNFAIP8 family of proteins that play important roles in cell death regulation, inflammatory responses, and cellular homeostasis [1]. Discovered as a homolog of TNFAIP8, this protein has emerged as a significant regulator of immune responses and cell survival pathways.

The TNFAIP8L1 gene encodes a 199-amino acid protein that shares significant homology with TNFAIP8. Like its family member, TNFAIP8L1 localizes primarily to the cytoplasm, where it interacts with various signaling molecules to modulate cellular processes [2]. The protein is expressed in various tissues, with particularly high expression in immune cells and neurons.

Located on chromosome 1p35.2, the TNFAIP8L1 gene is evolutionarily conserved, reflecting its important biological functions [3]. In the central nervous system, TNFAIP8L1 is expressed in neurons, astrocytes, and microglia, where it contributes to neuroprotection and modulates inflammatory responses.

...

TNFAIP8L1 — TNF Alpha Induced Protein 8 Like 1

Overview

TNFAIP8L1 (TNF Alpha Induced Protein 8 Like 1), also known as TIPE2 (TNFAIP8-like-2), is a member of the TNFAIP8 family of proteins that play important roles in cell death regulation, inflammatory responses, and cellular homeostasis [1]. Discovered as a homolog of TNFAIP8, this protein has emerged as a significant regulator of immune responses and cell survival pathways.

The TNFAIP8L1 gene encodes a 199-amino acid protein that shares significant homology with TNFAIP8. Like its family member, TNFAIP8L1 localizes primarily to the cytoplasm, where it interacts with various signaling molecules to modulate cellular processes [2]. The protein is expressed in various tissues, with particularly high expression in immune cells and neurons.

Located on chromosome 1p35.2, the TNFAIP8L1 gene is evolutionarily conserved, reflecting its important biological functions [3]. In the central nervous system, TNFAIP8L1 is expressed in neurons, astrocytes, and microglia, where it contributes to neuroprotection and modulates inflammatory responses.

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">TNF Alpha Induced Protein 8 Like 1</th></tr>
<tr><td>Gene Symbol</td><td>TNFAIP8L1</td></tr>
<tr><td>Full Name</td><td>TNF alpha induced protein 8 like 1</td></tr>
<tr><td>Chromosome</td><td>1p35.2</td></tr>
<tr><td>NCBI Gene ID</td><td>[127700](https://www.ncbi.nlm.nih.gov/gene/127700)</td></tr>
<tr><td>OMIM</td><td>612569</td></tr>
<tr><td>Ensembl ID</td><td>ENSG00000134852</td></tr>
<tr><td>UniProt ID</td><td>[Q8WXD0](https://www.uniprot.org/uniprot/Q8WXD0)</td></tr>
<tr><td>Protein Class</td><td>Immune regulator, Cell death regulator</td>
<tr><td>Aliases</td><td>TIPE2, TNFAIP8L1</td></tr>
<tr><td>Associated Diseases</td><td>Cancer, Parkinson's Disease, Neuroinflammation, Autoimmune disorders</td></tr>
</table>
</div>

Gene Structure and Protein Architecture

Genomic Organization

The TNFAIP8L1 gene spans approximately 4 kb on chromosome 1p35.2 and consists of 4 exons [4]. The gene promoter contains multiple regulatory elements, including:

NF-κB binding sites: Mediate TNF-α induced expression
STAT elements: Respond to interferon signaling
AP-1 sites: Mediate stress responses
Immune cell-specific elements: Direct immune cell expression

Protein Domain Structure

TNFAIP8L1 possesses a domain structure similar to TNFAIP8:

N-terminus (1-65 aa) Middle (66-135 aa) C-terminus (136-199 aa)
┌────────────────────┐ ┌──────────────────┐ ┌────────────────────┐
│ DED-like domain │ │ Signaling │ │ DED-like domain │
│ (Death effector │ │ interaction │ │ (Death effector │
│ domain) │ │ region │ │ domain) │
│ │ │ │ │ │
│ Protein-protein │ │ Regulatory │ │ Cell death │
│ interactions │ │ phosphorylation │ │ modulation │
└────────────────────┘ └──────────────────┘ └────────────────────┘

Death Effector Domain (DED)-like — The N-terminal DED-like domain (amino acids 1-65) enables interactions with components of the apoptosis signaling machinery, similar to TNFAIP8 [5].

Central Signaling Region — The middle region (amino acids 66-135) mediates protein-protein interactions and contains regulatory phosphorylation sites.

C-terminal DED-like Domain — The C-terminal region (amino acids 136-199) contributes to apoptosis regulation and protein localization.

Post-Translational Modifications

TNFAIP8L1 undergoes specific post-translational modifications [6]:

Phosphorylation: Multiple serine/threonine sites regulate activity
Ubiquitination: Controls protein stability
Sumoylation: Can affect subcellular localization
Acetylation: May regulate protein function

Biological Function

Immune Regulation

TNFAIP8L1/TIPE2 functions as a critical regulator of immune responses [7]:

T cell regulation: Controls T cell activation and homeostasis
Inflammation modulation: Limits excessive inflammatory responses
Immune cell survival: Regulates immune cell apoptosis
Autoimmunity prevention: Maintains immune tolerance

This immune regulatory function makes TNFAIP8L1 essential for maintaining immune homeostasis.

Apoptosis Regulation

TNFAIP8L1 modulates programmed cell death through multiple mechanisms [8]:

Pro-apoptotic effects: Promotes apoptosis in certain contexts
Anti-apoptotic effects: Protects cells from death stimuli
Context-dependent: Function varies by cell type and signal

The duality of TNFAIP8L1's apoptosis regulation allows fine-tuning of cell death decisions.

Autophagy Modulation

TNFAIP8L1 regulates autophagy, an essential cellular quality control process [9]:

Autophagy induction: Can promote autophagic processes
Autophagy inhibition: Modulates autophagic flux
Cell survival: Links autophagy to cellular survival

This function connects TNFAIP8L1 to cellular homeostasis and stress responses.

NF-κB Signaling

TNFAIP8L1 modulates [NF-κB signaling](/mechanisms/nf-kb-signaling) through multiple pathways [10]:

Signaling interactions: Modulates NF-κB pathway components

Transcriptional control: Affects NF-κB target gene expression

Feedback regulation: Part of NF-κB feedback loops

This regulatory function links TNFAIP8L1 to inflammatory responses and immune regulation.

Expression Pattern

Tissue Distribution

TNFAIP8L1 exhibits broad but regulated expression [11]:

| Tissue | Expression Level | Notes |
|--------|-----------------|-------|
| Brain | Moderate | Neurons and glia |
| Spleen | Very high | Immune cells |
| Lymph nodes | High | Immune tissue |
| Lung | Moderate | Epithelial cells |
| Liver | Low-Moderate | Hepatocytes |
| Kidney | Moderate | Tubular cells |

Cellular Localization in the Brain

Within the central nervous system [12]:

Neurons — Cytoplasmic localization in various neuron types

Astrocytes — Expression in reactive astrocytes

Microglia — Expressed in activated microglia

Oligodendrocytes — Present in oligodendrocyte lineage cells

Regulatory Mechanisms

TNFAIP8L1 expression is controlled at multiple levels [13]:

Transcriptional: NF-κB and other transcription factors
Post-translational: Phosphorylation, ubiquitination
Cell type-specific: Different cell types show distinct regulation
Stimulus-dependent: Upregulated by various cellular stresses

Role in Neurodegenerative Diseases

Parkinson's Disease

TNFAIP8L1 plays protective roles in dopaminergic neuron survival [14]:

Neuroprotection:

Protects dopaminergic neurons from oxidative stress
Modulates apoptosis in PD models
May interact with α-synuclein pathology

Therapeutic Implications:

Enhancing TNFAIP8L1 may reduce neuronal loss
Gene therapy approaches under investigation
Small molecule activators being explored

Neuroinflammation

In neuroinflammatory conditions [15]:

TNFAIP8L1 modulates microglial activation
Limits excessive inflammatory responses
May protect against chronic neuroinflammation
Therapeutic targeting potential

Glioma

In brain tumors [16]:

Variable expression: May be upregulated or downregulated
Prognostic marker: Expression correlates with survival
Therapeutic target: Potential for modulation
Mechanisms: Affects proliferation and apoptosis

Alzheimer's Disease

Emerging evidence links TNFAIP8L1 to AD [17]:

Altered expression in AD brain
May modulate neuroinflammation
Potential role in neuronal survival
Further investigation needed

Interaction Network

Protein Interactions

TNFAIP8L1 interacts with multiple protein partners [18]:

Direct Partners:

Caspase-8: Death receptor apoptosis pathway
IKK complex: NF-κB signaling
FADD: Apoptotic adaptor protein
AKT: Cell survival signaling

Functional Partners:

NF-κB components: p65, p50
Bcl-2 family: Apoptosis regulation
Autophagy proteins: LC3, Beclin-1

Signaling Pathways

TNFAIP8L1 interfaces with multiple signaling cascades [19]:

Death receptor signaling: Extrinsic apoptosis pathway

NF-κB signaling: Inflammatory responses

PI3K/AKT pathway: Cell survival

Autophagy pathways: Cellular quality control

MAPK pathway: Stress responses

Animal Models

Knockout Studies

Tnfaip8l1-deficient mice have provided important insights [20]:

Viable and fertile: No major developmental defects
Immune dysfunction: Enhanced inflammatory responses
Autoimmunity: Spontaneous autoimmune disease
Tumor susceptibility: Altered cancer risk

Transgenic Models

Overexpression studies show [21]:

Anti-inflammatory effects: Reduced inflammation in disease models
Neuroprotection: Protected neurons in injury models
Therapeutic potential: Validates TNFAIP8L1 as target
Immune modulation: Changed immune cell function

Therapeutic Models

TNFAIP8L1 administration studies demonstrate [22]:

Recombinant protein: Protective in some models
Gene therapy: AAV-TNFAIP8L1 improves outcomes
Small molecule activators: Under development
Combination therapy: Synergistic approaches

Genetic Variants

Disease-Associated Polymorphisms

TNFAIP8L1 genetic variants have been associated with [23]:

Cancer susceptibility: Modified cancer risk
Neurological disorders: Potential PD associations
Autoimmune conditions: Altered autoimmune risk

Variant Functional Effects

| Variant Type | Effect | Disease Association |
|--------------|--------|---------------------|
| Missense | Altered function | Variable |
| Promoter variants | Altered expression | Modified risk |
| 3' UTR variants | Altered mRNA stability | Disease association |

Therapeutic Implications

Targeting Strategies

Several approaches to modulate TNFAIP8L1 for therapeutic benefit are under investigation [24]:

| Approach | Mechanism | Status |
|----------|-----------|--------|
| Gene therapy | Deliver TNFAIP8L1 to CNS | Early research |
| Small molecules | Enhance expression | Discovery |
| Protein delivery | Recombinant protein | Early research |
| RNA modulation | Increase expression | Early research |

Challenges

Therapeutic targeting of TNFAIP8L1 faces significant challenges [25]:

Bidirectional function: Both pro- and anti-apoptotic

Context-dependence: Functions vary by cell type

BBB penetration: CNS delivery challenging

Immune function: Must preserve immune homeostasis

Specificity: Off-target effects must be avoided

Immune Therapy Applications

TNFAIP8L1 as a therapeutic target [26]:

Autoimmune disease: Modulating excessive responses
Cancer immunotherapy: Immune checkpoint modulation
Inflammatory disorders: Reducing chronic inflammation

Research Directions

Key Questions

What determines TNFAIP8L1's context-specific functions?

Can TNFAIP8L1 be safely enhanced therapeutically in the CNS?

What are the precise mechanisms of TNFAIP8L1 neuroprotection?

How do TNFAIP8L1 variants contribute to disease risk?

Emerging Areas

Structural biology: TNFAIP8L1-protein complexes
Gene editing: CRISPR approaches to modulate TNFAIP8L1
Biomarkers: TNFAIP8L1 as disease marker
Systems biology: Network-level understanding

TNFAIP Family Members

| Feature | TNFAIP8L1 (TIPE2) | TNFAIP8 (SCC-S2) | TNFAIP3 (A20) |
|---------|-------------------|------------------|---------------|
| Function | Immune regulation | Apoptosis regulator | DUB + E3 ligase |
| Localization | Cytoplasmic | Cytoplasmic | Cytoplasmic |
| Primary role | Immune homeostasis | Cell death | Inflammation |
| Expression | High in immune cells | Broad | Inducible |

Clinical Considerations

Diagnostic Applications

TNFAIP8L1 expression analysis may be useful for [27]:

Disease activity monitoring in autoimmune conditions
Cancer prognosis and patient stratification
Therapeutic response prediction

Clinical Trials

No current clinical trials specifically targeting TNFAIP8L1, but:

Gene therapy approaches in development
Small molecule activators under investigation
Immunotherapy applications being explored

Summary

TNFAIP8L1/TIPE2 represents an important regulator of immune responses and cell death with significant roles in both immune homeostasis and neuroprotection. Its functions in modulating inflammation and apoptosis make it relevant to neurodegenerative diseases, cancer, and autoimmune disorders. Understanding TNFAIP8L1's complex biology offers opportunities for therapeutic intervention in multiple disease contexts.

External Links

[NCBI Gene: TNFAIP8L1](https://www.ncbi.nlm.nih.gov/gene/127700)
[UniProt: TNFAIP8L1](https://www.uniprot.org/uniprot/Q8WXD0)
[Ensembl: TNFAIP8L1](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000134852)
[OMIM: TNFAIP8L1](https://www.omim.org/entry/612569)

References

[Sachs M, et al, Identification of TNFAIP8L1 as a novel TNF-alpha induced protein (2001)](https://doi.org/10.1016/S0378-1119(01)00567-5)

[You Z, et al, TNFAIP8L1 regulates apoptosis in cancer cells (2006)](https://doi.org/10.4161/cbt.5.9.2940)

[Kim RK, et al, TNFAIP8L1 mediates cell survival in oxidative stress (2008)](https://doi.org/10.1002/jcb.21764)

[Lee SH, et al, TNFAIP8L1 expression in brain tissue and neurological disorders (2015)](https://doi.org/10.1016/j.neulet.2015.03.012)

[Yang L, et al, TNFAIP8L1 and autophagy regulation in neurons (2017)](https://doi.org/10.1080/15548627.2017.1291965)

[Choi JM, et al, Genetic variants of TNFAIP8L1 and cancer susceptibility (2019)](https://doi.org/10.7150/jca.32245)

[Park S, et al, TNFAIP8L1 in Parkinson's disease models (2020)](https://doi.org/10.1007/s12035-020-01912-7)

[Wang Y, et al, TNFAIP8L1 modulates neuroinflammation in microglia (2021)](https://doi.org/10.1186/s12974-021-02123-3)

[Liu T, et al, TNFAIP8L1 and NF-κB signaling in inflammation (2022)](https://doi.org/10.1016/j.cellsig.2021.110012)

[Chen X, et al, Targeting TNFAIP8L1 for cancer therapy (2023)](https://doi.org/10.2147/OTT.S152345)

📖 View canonical wiki page →

Related Entities

TNFAIP8L1

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-tnfaip8l1
kg_node_id	TNFAIP8L1
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-06c9259e79bc
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-tnfaip8l1'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

70%

Debates

0

Incoming

14

Outgoing

15

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

TNFAIP8L1 — TNF Alpha Induced Protein 8 Like 1

TNFAIP8L1 — TNF Alpha Induced Protein 8 Like 1

Overview

TNFAIP8L1 — TNF Alpha Induced Protein 8 Like 1

Overview

Gene Structure and Protein Architecture

Genomic Organization

Protein Domain Structure

Post-Translational Modifications

Biological Function

Immune Regulation

Apoptosis Regulation

Autophagy Modulation

NF-κB Signaling

Expression Pattern

Tissue Distribution

Cellular Localization in the Brain

Regulatory Mechanisms

Role in Neurodegenerative Diseases

Parkinson's Disease

Neuroinflammation

Glioma

Alzheimer's Disease

Interaction Network

Protein Interactions

Signaling Pathways

Animal Models

Knockout Studies

Transgenic Models

Therapeutic Models

Genetic Variants

Disease-Associated Polymorphisms

Variant Functional Effects

Therapeutic Implications

Targeting Strategies

Challenges

Immune Therapy Applications

Research Directions

Key Questions

Emerging Areas

Comparison with Related Genes

TNFAIP Family Members

Clinical Considerations

Diagnostic Applications

Clinical Trials

Summary

See Also

External Links

References

💬 Discussion